Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418
Alfonso Cabello(Hospital Universitario Fundación Jiménez Díaz), Ignacio Valero(Instituto de Salud Carlos III), David Rial‐Crestelo, Rafael Micán(Hospital Universitario La Paz), Adriana Pinto Martínez, Herminia Esteban(Fundación Seimc-Gesida), Jesús Troya(Hospital Universitario Infanta Leonor), Carmen Busca(Hospital Universitario La Paz), Joanna Cano(Hospital Universitario La Paz), Alicia González Baeza(Universidad Autónoma de Madrid), Guillermo Cuevas(Hospital Universitario Infanta Leonor), Alberto Díaz de Santiago, Sara de la Fuente Moral(Hospital Universitario Puerta de Hierro Majadahonda), José Ignacio Bernardino Serna(Hospital Universitario La Paz), Mariana Díaz Almirón(Hospital La Paz Institute for Health Research), María Novella Mena(Hospital Universitario Príncipe de Asturias), Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), José Sanz Morerno(Hospital Universitario Príncipe de Asturias)
Cited by 12
Related Papers
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
|Proceedings of the National Academy of Sciences|2022|198
Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators
|The Journal of Infectious Diseases|2007|173
Hospital-Acquired Infectious Endocarditis Not Associated with Cardiac Surgery: An Emerging Problem
|Clinical Infectious Diseases|1995|170